Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2013
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancerKenji Tamura, Hiroaki Kurihara, Kan Yonemori, et al.
International Journal of Clinical Oncology|November 18, 2021
Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseasesMasanori Ono, Kimikazu Matsumoto, Narikazu Boku, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 2, 2017
Childbirth and fertility preservation in childhood and adolescent cancer patients: a second national survey of Japanese pediatric endocrinologistsYoko Miyoshi, Tohru Yorifuji, Reiko Horikawa, et al.
Breast Cancer (Tokyo, Japan)|December 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress ScaleYosuke Aoyama, Eri Hoshino, Akihiko Shimomura, et al.
Breast Cancer Research and Treatment|April 15, 2010
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 studyTomohiko Aihara, Yuichi Takatsuka, Shozo Ohsumi, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 24, 2016
Gonadal function, fertility, and reproductive medicine in childhood and adolescent cancer patients: a national survey of Japanese pediatric endocrinologistsYoko Miyoshi, Tohru Yorifuji, Reiko Horikawa, et al.
Journal of Adolescent and Young Adult Oncology|December 14, 2022
Current Status and Issues of the Japan Oncofertility RegistryKosuke Shigematsu, Chikako Shimizu, Tatsuro Furui, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon, Patrick Neven, Jens Huober, et al.
International Journal of Clinical Oncology|June 15, 2023
Effect of a web-based fertility preservation training program for medical professionals in JapanMasanori Ono, Miyuki Harada, Akihito Horie, et al.
JAMA Oncology|June 2, 2022
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical TrialMiguel Martin, Roberto Hegg, Sung-Bae Kim, et al.
Pageof 23